Laddar...
A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes
PURPOSE: To report the 5-year biochemical relapse-free survival (BRFS), overall survival (OS), and long-term toxicity outcomes of patients treated with low-dose-rate (LDR) brachytherapy as monotherapy for low- to intermediate-risk prostate cancer. MATERIAL AND METHODS: Between 2004 and 2011, 371 pat...
Sparad:
| I publikationen: | J Contemp Brachytherapy |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Termedia Publishing House
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5961530/ https://ncbi.nlm.nih.gov/pubmed/29789764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2018.75600 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|